Literature DB >> 8787037

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

R S Cohen1.   

Abstract

1. The objective of this paper was to provide an understanding of methylenedioxymethamphetamine (MDMA) use. This investigation provides the subjective effects that were reported by MDMA users. 2. There were a total of (500) humans who participated in this study. 3. Using a survey device, data from users were collected. Symptomatology associated with both the consumption of MDMA and its residual effects are documented. 4. Tables have been constructed to present prevalent psychological and physical side-effects associated with MDMA intake. 5. The results suggest that MDMA has significant implications with various psychological disorders and physical manifestations.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8787037     DOI： 10.1016/0278-5846(95)00231-6

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


  17 in total

1.  Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.

Authors:  H R Sumnall; L Jerome; R Doblin; M C Mithoefer
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

2.  The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).

Authors:  A C Parrott; J Rodgers; T Buchanan; A B Scholey; T Heffernan; J Ling
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

3.  Evidence for significant polydrug use among ecstasy-using college students.

Authors:  Eric D Wish; Dawn Bonanno Fitzelle; Kevin E O'Grady; Margaret H Hsu; Amelia M Arria
Journal:  J Am Coll Health       Date:  2006 Sep-Oct

4.  Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Authors:  Stephen J Kish; Jason Lerch; Yoshiaki Furukawa; Junchao Tong; Tina McCluskey; Diana Wilkins; Sylvain Houle; Jeffrey Meyer; Emanuela Mundo; Alan A Wilson; Pablo M Rusjan; Jean A Saint-Cyr; Mark Guttman; D Louis Collins; Colin Shapiro; Jerry J Warsh; Isabelle Boileau
Journal:  Brain       Date:  2010-05-17       Impact factor: 13.501

5.  A comparison of self-reported sexual effects of alcohol, marijuana, and ecstasy in a sample of young adult nightlife attendees.

Authors:  Joseph J Palamar; Marybec Griffin-Tomas; Patricia Acosta; Danielle C Ompad; Charles M Cleland
Journal:  Psychol Sex       Date:  2018-01-08

6.  The role of MDMA (Ecstasy) in coping with negative life situations among urban young adults.

Authors:  Lwendo S Moonzwe; Jean J Schensul; Kristin M Kostick
Journal:  J Psychoactive Drugs       Date:  2011 Jul-Sep

Review 7.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 8.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

9.  Functional MRI study of working memory in MDMA users.

Authors:  F Gerard Moeller; Joel L Steinberg; Donald M Dougherty; Ponnada A Narayana; Larry A Kramer; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2004-06-18       Impact factor: 4.530

10.  Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.